Source link : https://www.newshealth.biz/health-news/critics-say-fdas-use-of-surrogate-markers-falling-short/
Over the past few decades, the US Food and Drug Administration (FDA) has increasingly relied on surrogate measures such as blood tests instead of clinical outcomes for medication approvals. But critics say the agency lacks consistent standards to ensure the surrogate aligns with clinical outcomes that matter to patients — things like improvements in symptoms […]
Author : News Health
Publish date : 2024-05-17 11:36:40
Copyright for syndicated content belongs to the linked Source.
in Health